These unstable molecules are byproducts of natural processes like metabolism or external factors such as pollution, UV radiation, and smoking
Statins inhibit the mevalonate pathway, lowering endogenous CoQ10 levels, which may contribute to statin-associated muscle symptoms (SAMS) ( 3.2 Clinical evidence in heart failure The Q-SYMBIO trial (n = 420)administering 300 mg/day of CoQ10demonstrated improvements in New York Heart Association (NYHA) class, reductions in major adverse cardiovascular events (MACE) (HR 0.50, 95% CI 0.320.80), and lower all-cause mortality in patients with moderate-to-severe heart failure ( 3.3 Emerging data in heart failure with preserved ejection fraction and endothelial function A 2022 phase II, double-blind, randomized trial in patients with preserved ejection fraction (HFpEF) reported that ubiquinol (600 mg/day), alone or combined with D-ribose, modestly enhanced LVEF and alleviated symptom burden, though exercise capacity improvements were inconsistent ( 3.4 Statin-associated myopathy Although there is mechanistic plausibility for Coenzyme Q10 in alleviating SAMS, a 2021 meta-analysis identified no significant improvements in myalgia or creatine kinase levels relative to placebo ( 3.5 Practical considerations Formulation significantly influences Coenzyme Q10 bioavailability
The conversation also touched on the importance of ongoing research and monitoring of GLP1s long-term effects
Taking a pill that is unregulated by the FDA and has a high concentration of glutathione can present risks. Read the full story.
AOD-9604 does not protect against the hormonal consequences of severe restriction the way GLP-1 agonists do
Sources: Wharton S, Lingvay I, Bogdanski P, et al
